EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A One-Month Advanced Glycation End Products—Restricted Diet Improves CML, RAGE, Metabolic and Inflammatory Profile in Patients with End-Stage Renal Disease Undergoing Haemodialysis

Adamantia Aroni, Paraskevi Detopoulou iD, Demetrios Presvelos, Eirini Kostopoulou iD, Anastasios Ioannidis iD, George I Panoutsopoulos, Sofia Zyga, Georgios Kosmidis, Bessie E Spiliotis iD, Andrea Paola Rojas Gil iD

International Journal of Molecular Sciences · 15.08.2024 · 25 (16) · 8893

DOI: 10.3390/ijms25168893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.08.2024. Verfasst von Adamantia Aroni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Basic Health Sciences, Department of Nursing, Faculty of Health Sciences, University of Peloponnese, 22100 Tripoli, Greece. Hauptthemen laut MEDLINE: Renal Dialysis, Glycation End Products, Advanced, Kidney Failure, Chronic, Lysine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exogenous and endogenous advanced glycation end products (AGEs) contribute to the pathogenesis and progression of renal disease. This is a one-month controlled dietary counseling trial that restricts nutritional AGEs in patients with end-stage renal disease (ESRD) undergoing haemodialysis (n = 22 participants in the intervention and n = 20 participants in the control group). Haematological, biochemical markers, the soluble form of the receptor for AGEs (sRAGE), and carboxymethyl lysine (CML) were measured at baseline and at follow-up. Mononuclear cells were isolated and the protein expression of RAGE and the inflammatory marker COX-2 was measured using Western immunoblotting. The intervention group presented a lower increase in CML compared to the control group (12.39% median change in the intervention vs. 69.34% in the control group, p = 0.013), while RAGE (% mean change −56.54 in the intervention vs. 46.51 in the control group, p < 0.001) and COX-2 (% mean change −37.76 in the intervention vs. 0.27 in the control group, p < 0.001) were reduced compared to the control group. sRAGE was reduced in both groups. In addition, HbA1c (at two months), total cholesterol, and triglycerides were reduced in the intervention versus the control group. The adoption of healthy cooking methods deserves further research as a possible way of modulating inflammatory markers in patients with CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisGlycation End Products, AdvancedKidney Failure, ChronicLysineReceptor for Advanced Glycation End ProductsHumansMaleFemaleMiddle AgedAgedInflammationBiomarkersAdultCyclooxygenase 2

Stichwörter der Autor:innen

AGEschronic kidney diseasediethaemodialysis

Substanzen

Glycation End Products, AdvancedLysineReceptor for Advanced Glycation End ProductsN(6)-carboxymethyllysineBiomarkersCyclooxygenase 2

Autor:innen und Institutionen

  • Laboratory of Basic Health Sciences, Department of Nursing, Faculty of Health Sciences, University of Peloponnese, 22100 Tripoli, Greece.
  • Haemodialysis Unit, General Hospital of Molaoi, 23052 Molaoi, Greece.
  • Department of Nutritional Science and Dietetics, Faculty of Health Sciences, University of Peloponnese, New Building, Antikalamos, 24100 Kalamata, Greece.
  • Department of Clinical Nutrition, General Hospital Korgialenio Benakio, Athanassaki 2, 11526 Athens, Greece.
  • Department of Paediatrics, Research Laboratory of the Division of Pediatric Endocrinology and Diabetes, University of Patras School of Medicine, 26504 Patras, Greece.
  • Laboratory of Nursing Research and Care, School of Health Sciences Department of Nursing, University of Peloponnese, 22100 Tripoli, Greece.

ORCID-Profile: Paraskevi Detopoulou, Eirini Kostopoulou, Anastasios Ioannidis, Bessie E Spiliotis, Andrea Paola Rojas Gil

Zitieren

APA

Aroni, A., Detopoulou, P., Presvelos, D., Kostopoulou, E., Ioannidis, A., Panoutsopoulos, G. I., Zyga, S., Kosmidis, G., Spiliotis, B. E., & Rojas Gil, A. P. (2024). A One-Month Advanced Glycation End Products—Restricted Diet Improves CML, RAGE, Metabolic and Inflammatory Profile in Patients with End-Stage Renal Disease Undergoing Haemodialysis. International Journal of Molecular Sciences, 25(16), 8893. https://doi.org/10.3390/ijms25168893

Vancouver

Aroni A, Detopoulou P, Presvelos D, Kostopoulou E, Ioannidis A, Panoutsopoulos GI, et al. A One-Month Advanced Glycation End Products—Restricted Diet Improves CML, RAGE, Metabolic and Inflammatory Profile in Patients with End-Stage Renal Disease Undergoing Haemodialysis. International Journal of Molecular Sciences. 2024;25(16):8893. doi:10.3390/ijms25168893

BibTeX
@article{Aroni2024,
  author = {Aroni, Adamantia and Detopoulou, Paraskevi and Presvelos, Demetrios and Kostopoulou, Eirini and Ioannidis, Anastasios and Panoutsopoulos, George I and Zyga, Sofia and Kosmidis, Georgios and Spiliotis, Bessie E and Rojas Gil, Andrea Paola},
  title = {A One-Month Advanced Glycation End Products—Restricted Diet Improves CML, RAGE, Metabolic and Inflammatory Profile in Patients with End-Stage Renal Disease Undergoing Haemodialysis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {16},
  pages = {8893},
  doi = {10.3390/ijms25168893}
}
Kostenlos starten →